We invite you to watch our on-demand webinar on nitrosamines and NDSRIs, where we explore their analysis and impact within the pharmaceutical industry. Nitrosamines, a group of potentially carcinogenic impurities, have received significant attention in recent years due to their detection in certain drug substances. Understanding their analytical characteristics is critical to ensuring patient safety and meeting evolving regulatory requirements.

Access the recording at your convenience and gain valuable insights into pharmaceutical analysis.

Key discussion points include:

• Overview of nitrosamines and NDSRIs
• Analytical techniques for detection and quantification
• Regulatory landscape and compliance considerations
• Real case studies of drug substances
• Column selection strategies for nitrosamine analysis

Watch now to stay informed and strengthen your analytical approach.